Medical Care
Global Oral Antidiabetic Agents Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 1660
- Pages: 113
- Figures: 133
- Views: 1
Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there are five distinct classes of hypoglycemic agents available include sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha-glucosidase inhibitors.
Market Analysis and Insights: Global Oral Antidiabetic Agents Market
The global Oral Antidiabetic Agents market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oral Antidiabetic Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Oral Antidiabetic Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Oral Antidiabetic Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Oral Antidiabetic Agents include Novo Nordisk, Eli Lilly, Sanofi, Roche, Teva, AstraZeneca, Wockhardt UK, Merck and Pfizer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Oral Antidiabetic Agents is widely used in various fields, such as Home Use, Medical Institutions and Others,, etc. Home Use provides greatest supports to the Oral Antidiabetic Agents industry development. In 2023, global % revenue of Oral Antidiabetic Agents went into Home Use filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Oral Antidiabetic Agents market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Oral Antidiabetic Agents, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Oral Antidiabetic Agents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Antidiabetic Agents revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Oral Antidiabetic Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Oral Antidiabetic Agents revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Novo Nordisk
Eli Lilly
Sanofi
Roche
Teva
AstraZeneca
Wockhardt UK
Merck
Pfizer
Cipla
Segment by Type
Sulfonylureas
Meglitinides
Biguanides
Thiazolidinediones
Alpha-glucosidase Inhibitors
Segment by Application
Home Use
Medical Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Oral Antidiabetic Agents in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Antidiabetic Agents companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Antidiabetic Agents revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Oral Antidiabetic Agents Market
The global Oral Antidiabetic Agents market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oral Antidiabetic Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Oral Antidiabetic Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Oral Antidiabetic Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Oral Antidiabetic Agents include Novo Nordisk, Eli Lilly, Sanofi, Roche, Teva, AstraZeneca, Wockhardt UK, Merck and Pfizer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Oral Antidiabetic Agents is widely used in various fields, such as Home Use, Medical Institutions and Others,, etc. Home Use provides greatest supports to the Oral Antidiabetic Agents industry development. In 2023, global % revenue of Oral Antidiabetic Agents went into Home Use filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Oral Antidiabetic Agents market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Oral Antidiabetic Agents, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Oral Antidiabetic Agents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Antidiabetic Agents revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Oral Antidiabetic Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Oral Antidiabetic Agents revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Novo Nordisk
Eli Lilly
Sanofi
Roche
Teva
AstraZeneca
Wockhardt UK
Merck
Pfizer
Cipla
Segment by Type
Sulfonylureas
Meglitinides
Biguanides
Thiazolidinediones
Alpha-glucosidase Inhibitors
Segment by Application
Home Use
Medical Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Oral Antidiabetic Agents in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Antidiabetic Agents companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Antidiabetic Agents revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Antidiabetic Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Sulfonylureas
1.2.3 Meglitinides
1.2.4 Biguanides
1.2.5 Thiazolidinediones
1.2.6 Alpha-glucosidase Inhibitors
1.3 Market by Application
1.3.1 Global Oral Antidiabetic Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Home Use
1.3.3 Medical Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Antidiabetic Agents Market Perspective (2019-2030)
2.2 Global Oral Antidiabetic Agents Growth Trends by Region
2.2.1 Oral Antidiabetic Agents Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oral Antidiabetic Agents Historic Market Size by Region (2019-2024)
2.2.3 Oral Antidiabetic Agents Forecasted Market Size by Region (2025-2030)
2.3 Oral Antidiabetic Agents Market Dynamics
2.3.1 Oral Antidiabetic Agents Industry Trends
2.3.2 Oral Antidiabetic Agents Market Drivers
2.3.3 Oral Antidiabetic Agents Market Challenges
2.3.4 Oral Antidiabetic Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Oral Antidiabetic Agents by Players
3.1.1 Global Oral Antidiabetic Agents Revenue by Players (2019-2024)
3.1.2 Global Oral Antidiabetic Agents Revenue Market Share by Players (2019-2024)
3.2 Global Oral Antidiabetic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Oral Antidiabetic Agents, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Oral Antidiabetic Agents Market Concentration Ratio
3.4.1 Global Oral Antidiabetic Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Antidiabetic Agents Revenue in 2023
3.5 Global Key Players of Oral Antidiabetic Agents Head office and Area Served
3.6 Global Key Players of Oral Antidiabetic Agents, Product and Application
3.7 Global Key Players of Oral Antidiabetic Agents, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Antidiabetic Agents Breakdown Data by Type
4.1 Global Oral Antidiabetic Agents Historic Market Size by Type (2019-2024)
4.2 Global Oral Antidiabetic Agents Forecasted Market Size by Type (2025-2030)
5 Oral Antidiabetic Agents Breakdown Data by Application
5.1 Global Oral Antidiabetic Agents Historic Market Size by Application (2019-2024)
5.2 Global Oral Antidiabetic Agents Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oral Antidiabetic Agents Market Size (2019-2030)
6.2 North America Oral Antidiabetic Agents Market Size by Type
6.2.1 North America Oral Antidiabetic Agents Market Size by Type (2019-2024)
6.2.2 North America Oral Antidiabetic Agents Market Size by Type (2025-2030)
6.2.3 North America Oral Antidiabetic Agents Market Share by Type (2019-2030)
6.3 North America Oral Antidiabetic Agents Market Size by Application
6.3.1 North America Oral Antidiabetic Agents Market Size by Application (2019-2024)
6.3.2 North America Oral Antidiabetic Agents Market Size by Application (2025-2030)
6.3.3 North America Oral Antidiabetic Agents Market Share by Application (2019-2030)
6.4 North America Oral Antidiabetic Agents Market Size by Country
6.4.1 North America Oral Antidiabetic Agents Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Oral Antidiabetic Agents Market Size by Country (2019-2024)
6.4.3 North America Oral Antidiabetic Agents Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Oral Antidiabetic Agents Market Size (2019-2030)
7.2 Europe Oral Antidiabetic Agents Market Size by Type
7.2.1 Europe Oral Antidiabetic Agents Market Size by Type (2019-2024)
7.2.2 Europe Oral Antidiabetic Agents Market Size by Type (2025-2030)
7.2.3 Europe Oral Antidiabetic Agents Market Share by Type (2019-2030)
7.3 Europe Oral Antidiabetic Agents Market Size by Application
7.3.1 Europe Oral Antidiabetic Agents Market Size by Application (2019-2024)
7.3.2 Europe Oral Antidiabetic Agents Market Size by Application (2025-2030)
7.3.3 Europe Oral Antidiabetic Agents Market Share by Application (2019-2030)
7.4 Europe Oral Antidiabetic Agents Market Size by Country
7.4.1 Europe Oral Antidiabetic Agents Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Oral Antidiabetic Agents Market Size by Country (2019-2024)
7.4.3 Europe Oral Antidiabetic Agents Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Oral Antidiabetic Agents Market Size (2019-2030)
8.2 China Oral Antidiabetic Agents Market Size by Type
8.2.1 China Oral Antidiabetic Agents Market Size by Type (2019-2024)
8.2.2 China Oral Antidiabetic Agents Market Size by Type (2025-2030)
8.2.3 China Oral Antidiabetic Agents Market Share by Type (2019-2030)
8.3 China Oral Antidiabetic Agents Market Size by Application
8.3.1 China Oral Antidiabetic Agents Market Size by Application (2019-2024)
8.3.2 China Oral Antidiabetic Agents Market Size by Application (2025-2030)
8.3.3 China Oral Antidiabetic Agents Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Oral Antidiabetic Agents Market Size (2019-2030)
9.2 Asia Oral Antidiabetic Agents Market Size by Type
9.2.1 Asia Oral Antidiabetic Agents Market Size by Type (2019-2024)
9.2.2 Asia Oral Antidiabetic Agents Market Size by Type (2025-2030)
9.2.3 Asia Oral Antidiabetic Agents Market Share by Type (2019-2030)
9.3 Asia Oral Antidiabetic Agents Market Size by Application
9.3.1 Asia Oral Antidiabetic Agents Market Size by Application (2019-2024)
9.3.2 Asia Oral Antidiabetic Agents Market Size by Application (2025-2030)
9.3.3 Asia Oral Antidiabetic Agents Market Share by Application (2019-2030)
9.4 Asia Oral Antidiabetic Agents Market Size by Region
9.4.1 Asia Oral Antidiabetic Agents Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Oral Antidiabetic Agents Market Size by Region (2019-2024)
9.4.3 Asia Oral Antidiabetic Agents Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Type
10.2.1 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Application
10.3.1 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country
10.4.1 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Oral Antidiabetic Agents Introduction
11.1.4 Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.1.5 Novo Nordisk Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Oral Antidiabetic Agents Introduction
11.2.4 Eli Lilly Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.2.5 Eli Lilly Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Oral Antidiabetic Agents Introduction
11.3.4 Sanofi Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.3.5 Sanofi Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Oral Antidiabetic Agents Introduction
11.4.4 Roche Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.4.5 Roche Recent Developments
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Oral Antidiabetic Agents Introduction
11.5.4 Teva Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.5.5 Teva Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Oral Antidiabetic Agents Introduction
11.6.4 AstraZeneca Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.6.5 AstraZeneca Recent Developments
11.7 Wockhardt UK
11.7.1 Wockhardt UK Company Details
11.7.2 Wockhardt UK Business Overview
11.7.3 Wockhardt UK Oral Antidiabetic Agents Introduction
11.7.4 Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.7.5 Wockhardt UK Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Oral Antidiabetic Agents Introduction
11.8.4 Merck Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.8.5 Merck Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Oral Antidiabetic Agents Introduction
11.9.4 Pfizer Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.9.5 Pfizer Recent Developments
11.10 Cipla
11.10.1 Cipla Company Details
11.10.2 Cipla Business Overview
11.10.3 Cipla Oral Antidiabetic Agents Introduction
11.10.4 Cipla Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.10.5 Cipla Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Antidiabetic Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Sulfonylureas
1.2.3 Meglitinides
1.2.4 Biguanides
1.2.5 Thiazolidinediones
1.2.6 Alpha-glucosidase Inhibitors
1.3 Market by Application
1.3.1 Global Oral Antidiabetic Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Home Use
1.3.3 Medical Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Antidiabetic Agents Market Perspective (2019-2030)
2.2 Global Oral Antidiabetic Agents Growth Trends by Region
2.2.1 Oral Antidiabetic Agents Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oral Antidiabetic Agents Historic Market Size by Region (2019-2024)
2.2.3 Oral Antidiabetic Agents Forecasted Market Size by Region (2025-2030)
2.3 Oral Antidiabetic Agents Market Dynamics
2.3.1 Oral Antidiabetic Agents Industry Trends
2.3.2 Oral Antidiabetic Agents Market Drivers
2.3.3 Oral Antidiabetic Agents Market Challenges
2.3.4 Oral Antidiabetic Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Oral Antidiabetic Agents by Players
3.1.1 Global Oral Antidiabetic Agents Revenue by Players (2019-2024)
3.1.2 Global Oral Antidiabetic Agents Revenue Market Share by Players (2019-2024)
3.2 Global Oral Antidiabetic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Oral Antidiabetic Agents, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Oral Antidiabetic Agents Market Concentration Ratio
3.4.1 Global Oral Antidiabetic Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Antidiabetic Agents Revenue in 2023
3.5 Global Key Players of Oral Antidiabetic Agents Head office and Area Served
3.6 Global Key Players of Oral Antidiabetic Agents, Product and Application
3.7 Global Key Players of Oral Antidiabetic Agents, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Antidiabetic Agents Breakdown Data by Type
4.1 Global Oral Antidiabetic Agents Historic Market Size by Type (2019-2024)
4.2 Global Oral Antidiabetic Agents Forecasted Market Size by Type (2025-2030)
5 Oral Antidiabetic Agents Breakdown Data by Application
5.1 Global Oral Antidiabetic Agents Historic Market Size by Application (2019-2024)
5.2 Global Oral Antidiabetic Agents Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oral Antidiabetic Agents Market Size (2019-2030)
6.2 North America Oral Antidiabetic Agents Market Size by Type
6.2.1 North America Oral Antidiabetic Agents Market Size by Type (2019-2024)
6.2.2 North America Oral Antidiabetic Agents Market Size by Type (2025-2030)
6.2.3 North America Oral Antidiabetic Agents Market Share by Type (2019-2030)
6.3 North America Oral Antidiabetic Agents Market Size by Application
6.3.1 North America Oral Antidiabetic Agents Market Size by Application (2019-2024)
6.3.2 North America Oral Antidiabetic Agents Market Size by Application (2025-2030)
6.3.3 North America Oral Antidiabetic Agents Market Share by Application (2019-2030)
6.4 North America Oral Antidiabetic Agents Market Size by Country
6.4.1 North America Oral Antidiabetic Agents Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Oral Antidiabetic Agents Market Size by Country (2019-2024)
6.4.3 North America Oral Antidiabetic Agents Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Oral Antidiabetic Agents Market Size (2019-2030)
7.2 Europe Oral Antidiabetic Agents Market Size by Type
7.2.1 Europe Oral Antidiabetic Agents Market Size by Type (2019-2024)
7.2.2 Europe Oral Antidiabetic Agents Market Size by Type (2025-2030)
7.2.3 Europe Oral Antidiabetic Agents Market Share by Type (2019-2030)
7.3 Europe Oral Antidiabetic Agents Market Size by Application
7.3.1 Europe Oral Antidiabetic Agents Market Size by Application (2019-2024)
7.3.2 Europe Oral Antidiabetic Agents Market Size by Application (2025-2030)
7.3.3 Europe Oral Antidiabetic Agents Market Share by Application (2019-2030)
7.4 Europe Oral Antidiabetic Agents Market Size by Country
7.4.1 Europe Oral Antidiabetic Agents Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Oral Antidiabetic Agents Market Size by Country (2019-2024)
7.4.3 Europe Oral Antidiabetic Agents Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Oral Antidiabetic Agents Market Size (2019-2030)
8.2 China Oral Antidiabetic Agents Market Size by Type
8.2.1 China Oral Antidiabetic Agents Market Size by Type (2019-2024)
8.2.2 China Oral Antidiabetic Agents Market Size by Type (2025-2030)
8.2.3 China Oral Antidiabetic Agents Market Share by Type (2019-2030)
8.3 China Oral Antidiabetic Agents Market Size by Application
8.3.1 China Oral Antidiabetic Agents Market Size by Application (2019-2024)
8.3.2 China Oral Antidiabetic Agents Market Size by Application (2025-2030)
8.3.3 China Oral Antidiabetic Agents Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Oral Antidiabetic Agents Market Size (2019-2030)
9.2 Asia Oral Antidiabetic Agents Market Size by Type
9.2.1 Asia Oral Antidiabetic Agents Market Size by Type (2019-2024)
9.2.2 Asia Oral Antidiabetic Agents Market Size by Type (2025-2030)
9.2.3 Asia Oral Antidiabetic Agents Market Share by Type (2019-2030)
9.3 Asia Oral Antidiabetic Agents Market Size by Application
9.3.1 Asia Oral Antidiabetic Agents Market Size by Application (2019-2024)
9.3.2 Asia Oral Antidiabetic Agents Market Size by Application (2025-2030)
9.3.3 Asia Oral Antidiabetic Agents Market Share by Application (2019-2030)
9.4 Asia Oral Antidiabetic Agents Market Size by Region
9.4.1 Asia Oral Antidiabetic Agents Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Oral Antidiabetic Agents Market Size by Region (2019-2024)
9.4.3 Asia Oral Antidiabetic Agents Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Type
10.2.1 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Application
10.3.1 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country
10.4.1 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Oral Antidiabetic Agents Introduction
11.1.4 Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.1.5 Novo Nordisk Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Oral Antidiabetic Agents Introduction
11.2.4 Eli Lilly Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.2.5 Eli Lilly Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Oral Antidiabetic Agents Introduction
11.3.4 Sanofi Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.3.5 Sanofi Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Oral Antidiabetic Agents Introduction
11.4.4 Roche Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.4.5 Roche Recent Developments
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Oral Antidiabetic Agents Introduction
11.5.4 Teva Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.5.5 Teva Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Oral Antidiabetic Agents Introduction
11.6.4 AstraZeneca Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.6.5 AstraZeneca Recent Developments
11.7 Wockhardt UK
11.7.1 Wockhardt UK Company Details
11.7.2 Wockhardt UK Business Overview
11.7.3 Wockhardt UK Oral Antidiabetic Agents Introduction
11.7.4 Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.7.5 Wockhardt UK Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Oral Antidiabetic Agents Introduction
11.8.4 Merck Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.8.5 Merck Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Oral Antidiabetic Agents Introduction
11.9.4 Pfizer Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.9.5 Pfizer Recent Developments
11.10 Cipla
11.10.1 Cipla Company Details
11.10.2 Cipla Business Overview
11.10.3 Cipla Oral Antidiabetic Agents Introduction
11.10.4 Cipla Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.10.5 Cipla Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Oral Antidiabetic Agents Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Sulfonylureas
Table 3. Key Players of Meglitinides
Table 4. Key Players of Biguanides
Table 5. Key Players of Thiazolidinediones
Table 6. Key Players of Alpha-glucosidase Inhibitors
Table 7. Global Oral Antidiabetic Agents Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 8. Global Oral Antidiabetic Agents Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Oral Antidiabetic Agents Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Oral Antidiabetic Agents Market Share by Region (2019-2024)
Table 11. Global Oral Antidiabetic Agents Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Oral Antidiabetic Agents Market Share by Region (2025-2030)
Table 13. Oral Antidiabetic Agents Market Trends
Table 14. Oral Antidiabetic Agents Market Drivers
Table 15. Oral Antidiabetic Agents Market Challenges
Table 16. Oral Antidiabetic Agents Market Restraints
Table 17. Global Oral Antidiabetic Agents Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Oral Antidiabetic Agents Revenue Share by Players (2019-2024)
Table 19. Global Top Oral Antidiabetic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Agents as of 2023)
Table 20. Global Oral Antidiabetic Agents Industry Ranking 2022 VS 2023 VS 2024
Table 21. Global 5 Largest Players Market Share by Oral Antidiabetic Agents Revenue (CR5 and HHI) & (2019-2024)
Table 22. Global Key Players of Oral Antidiabetic Agents, Headquarters and Area Served
Table 23. Global Key Players of Oral Antidiabetic Agents, Product and Application
Table 24. Global Key Players of Oral Antidiabetic Agents, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Oral Antidiabetic Agents Revenue Market Share by Type (2019-2024)
Table 28. Global Oral Antidiabetic Agents Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Oral Antidiabetic Agents Revenue Market Share by Type (2025-2030)
Table 30. Global Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Oral Antidiabetic Agents Revenue Share by Application (2019-2024)
Table 32. Global Oral Antidiabetic Agents Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Oral Antidiabetic Agents Revenue Share by Application (2025-2030)
Table 34. North America Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)
Table 35. North America Oral Antidiabetic Agents Market Size by Type (2025-2030) & (US$ Million)
Table 36. North America Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)
Table 37. North America Oral Antidiabetic Agents Market Size by Application (2025-2030) & (US$ Million)
Table 38. North America Oral Antidiabetic Agents Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. North America Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)
Table 40. North America Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)
Table 41. Europe Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)
Table 42. Europe Oral Antidiabetic Agents Market Size by Type (2025-2030) & (US$ Million)
Table 43. Europe Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)
Table 44. Europe Oral Antidiabetic Agents Market Size by Application (2025-2030) & (US$ Million)
Table 45. Europe Oral Antidiabetic Agents Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Europe Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)
Table 47. Europe Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)
Table 48. China Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)
Table 49. China Oral Antidiabetic Agents Market Size by Type (2025-2030) & (US$ Million)
Table 50. China Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)
Table 51. China Oral Antidiabetic Agents Market Size by Application (2025-2030) & (US$ Million)
Table 52. Asia Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)
Table 53. Asia Oral Antidiabetic Agents Market Size by Type (2025-2030) & (US$ Million)
Table 54. Asia Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)
Table 55. Asia Oral Antidiabetic Agents Market Size by Application (2025-2030) & (US$ Million)
Table 56. Asia Oral Antidiabetic Agents Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 57. Asia Oral Antidiabetic Agents Market Size by Region (2019-2024) & (US$ Million)
Table 58. Asia Oral Antidiabetic Agents Market Size by Region (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Type (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Application (2025-2030) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Oral Antidiabetic Agents Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 64. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)
Table 66. Novo Nordisk Company Details
Table 67. Novo Nordisk Business Overview
Table 68. Novo Nordisk Oral Antidiabetic Agents Product
Table 69. Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 70. Novo Nordisk Recent Developments
Table 71. Eli Lilly Company Details
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly Oral Antidiabetic Agents Product
Table 74. Eli Lilly Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 75. Eli Lilly Recent Developments
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi Oral Antidiabetic Agents Product
Table 79. Sanofi Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 80. Sanofi Recent Developments
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Oral Antidiabetic Agents Product
Table 84. Roche Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 85. Roche Recent Developments
Table 86. Teva Company Details
Table 87. Teva Business Overview
Table 88. Teva Oral Antidiabetic Agents Product
Table 89. Teva Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 90. Teva Recent Developments
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Oral Antidiabetic Agents Product
Table 94. AstraZeneca Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 95. AstraZeneca Recent Developments
Table 96. Wockhardt UK Company Details
Table 97. Wockhardt UK Business Overview
Table 98. Wockhardt UK Oral Antidiabetic Agents Product
Table 99. Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 100. Wockhardt UK Recent Developments
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Oral Antidiabetic Agents Product
Table 104. Merck Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 105. Merck Recent Developments
Table 106. Pfizer Company Details
Table 107. Pfizer Business Overview
Table 108. Pfizer Oral Antidiabetic Agents Product
Table 109. Pfizer Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 110. Pfizer Recent Developments
Table 111. Cipla Company Details
Table 112. Cipla Business Overview
Table 113. Cipla Oral Antidiabetic Agents Product
Table 114. Cipla Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 115. Cipla Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Antidiabetic Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Oral Antidiabetic Agents Market Share by Type: 2023 VS 2030
Figure 3. Sulfonylureas Features
Figure 4. Meglitinides Features
Figure 5. Biguanides Features
Figure 6. Thiazolidinediones Features
Figure 7. Alpha-glucosidase Inhibitors Features
Figure 8. Global Oral Antidiabetic Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Oral Antidiabetic Agents Market Share by Application: 2023 VS 2030
Figure 10. Home Use Case Studies
Figure 11. Medical Institutions Case Studies
Figure 12. Others Case Studies
Figure 13. Oral Antidiabetic Agents Report Years Considered
Figure 14. Global Oral Antidiabetic Agents Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Oral Antidiabetic Agents Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Oral Antidiabetic Agents Market Share by Region: 2023 VS 2030
Figure 17. Global Oral Antidiabetic Agents Market Share by Players in 2023
Figure 18. Global Top Oral Antidiabetic Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Agents as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Oral Antidiabetic Agents Revenue in 2023
Figure 20. North America Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Oral Antidiabetic Agents Market Share by Type (2019-2030)
Figure 22. North America Oral Antidiabetic Agents Market Share by Application (2019-2030)
Figure 23. North America Oral Antidiabetic Agents Market Share by Country (2019-2030)
Figure 24. United States Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Oral Antidiabetic Agents Market Size YoY (2019-2030) & (US$ Million)
Figure 27. Europe Oral Antidiabetic Agents Market Share by Type (2019-2030)
Figure 28. Europe Oral Antidiabetic Agents Market Share by Application (2019-2030)
Figure 29. Europe Oral Antidiabetic Agents Market Share by Country (2019-2030)
Figure 30. Germany Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. China Oral Antidiabetic Agents Market Size YoY (2019-2030) & (US$ Million)
Figure 37. China Oral Antidiabetic Agents Market Share by Type (2019-2030)
Figure 38. China Oral Antidiabetic Agents Market Share by Application (2019-2030)
Figure 39. Asia Oral Antidiabetic Agents Market Size YoY (2019-2030) & (US$ Million)
Figure 40. Asia Oral Antidiabetic Agents Market Share by Type (2019-2030)
Figure 41. Asia Oral Antidiabetic Agents Market Share by Application (2019-2030)
Figure 42. Asia Oral Antidiabetic Agents Market Share by Region (2019-2030)
Figure 43. Japan Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. South Korea Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Taiwan Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. India Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Australia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size YoY (2019-2030) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Share by Type (2019-2030)
Figure 51. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Share by Application (2019-2030)
Figure 52. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Share by Country (2019-2030)
Figure 53. Brazil Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Mexico Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Turkey Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Israel Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. GCC Countries Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Novo Nordisk Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 60. Eli Lilly Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 61. Sanofi Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 62. Roche Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 63. Teva Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 64. AstraZeneca Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 65. Wockhardt UK Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 66. Merck Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 67. Pfizer Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 68. Cipla Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Table 1. Global Oral Antidiabetic Agents Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Sulfonylureas
Table 3. Key Players of Meglitinides
Table 4. Key Players of Biguanides
Table 5. Key Players of Thiazolidinediones
Table 6. Key Players of Alpha-glucosidase Inhibitors
Table 7. Global Oral Antidiabetic Agents Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 8. Global Oral Antidiabetic Agents Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Oral Antidiabetic Agents Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Oral Antidiabetic Agents Market Share by Region (2019-2024)
Table 11. Global Oral Antidiabetic Agents Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Oral Antidiabetic Agents Market Share by Region (2025-2030)
Table 13. Oral Antidiabetic Agents Market Trends
Table 14. Oral Antidiabetic Agents Market Drivers
Table 15. Oral Antidiabetic Agents Market Challenges
Table 16. Oral Antidiabetic Agents Market Restraints
Table 17. Global Oral Antidiabetic Agents Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Oral Antidiabetic Agents Revenue Share by Players (2019-2024)
Table 19. Global Top Oral Antidiabetic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Agents as of 2023)
Table 20. Global Oral Antidiabetic Agents Industry Ranking 2022 VS 2023 VS 2024
Table 21. Global 5 Largest Players Market Share by Oral Antidiabetic Agents Revenue (CR5 and HHI) & (2019-2024)
Table 22. Global Key Players of Oral Antidiabetic Agents, Headquarters and Area Served
Table 23. Global Key Players of Oral Antidiabetic Agents, Product and Application
Table 24. Global Key Players of Oral Antidiabetic Agents, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Oral Antidiabetic Agents Revenue Market Share by Type (2019-2024)
Table 28. Global Oral Antidiabetic Agents Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Oral Antidiabetic Agents Revenue Market Share by Type (2025-2030)
Table 30. Global Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Oral Antidiabetic Agents Revenue Share by Application (2019-2024)
Table 32. Global Oral Antidiabetic Agents Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Oral Antidiabetic Agents Revenue Share by Application (2025-2030)
Table 34. North America Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)
Table 35. North America Oral Antidiabetic Agents Market Size by Type (2025-2030) & (US$ Million)
Table 36. North America Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)
Table 37. North America Oral Antidiabetic Agents Market Size by Application (2025-2030) & (US$ Million)
Table 38. North America Oral Antidiabetic Agents Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. North America Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)
Table 40. North America Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)
Table 41. Europe Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)
Table 42. Europe Oral Antidiabetic Agents Market Size by Type (2025-2030) & (US$ Million)
Table 43. Europe Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)
Table 44. Europe Oral Antidiabetic Agents Market Size by Application (2025-2030) & (US$ Million)
Table 45. Europe Oral Antidiabetic Agents Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Europe Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)
Table 47. Europe Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)
Table 48. China Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)
Table 49. China Oral Antidiabetic Agents Market Size by Type (2025-2030) & (US$ Million)
Table 50. China Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)
Table 51. China Oral Antidiabetic Agents Market Size by Application (2025-2030) & (US$ Million)
Table 52. Asia Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)
Table 53. Asia Oral Antidiabetic Agents Market Size by Type (2025-2030) & (US$ Million)
Table 54. Asia Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)
Table 55. Asia Oral Antidiabetic Agents Market Size by Application (2025-2030) & (US$ Million)
Table 56. Asia Oral Antidiabetic Agents Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 57. Asia Oral Antidiabetic Agents Market Size by Region (2019-2024) & (US$ Million)
Table 58. Asia Oral Antidiabetic Agents Market Size by Region (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Type (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Application (2025-2030) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Oral Antidiabetic Agents Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 64. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)
Table 66. Novo Nordisk Company Details
Table 67. Novo Nordisk Business Overview
Table 68. Novo Nordisk Oral Antidiabetic Agents Product
Table 69. Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 70. Novo Nordisk Recent Developments
Table 71. Eli Lilly Company Details
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly Oral Antidiabetic Agents Product
Table 74. Eli Lilly Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 75. Eli Lilly Recent Developments
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi Oral Antidiabetic Agents Product
Table 79. Sanofi Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 80. Sanofi Recent Developments
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Oral Antidiabetic Agents Product
Table 84. Roche Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 85. Roche Recent Developments
Table 86. Teva Company Details
Table 87. Teva Business Overview
Table 88. Teva Oral Antidiabetic Agents Product
Table 89. Teva Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 90. Teva Recent Developments
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Oral Antidiabetic Agents Product
Table 94. AstraZeneca Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 95. AstraZeneca Recent Developments
Table 96. Wockhardt UK Company Details
Table 97. Wockhardt UK Business Overview
Table 98. Wockhardt UK Oral Antidiabetic Agents Product
Table 99. Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 100. Wockhardt UK Recent Developments
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Oral Antidiabetic Agents Product
Table 104. Merck Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 105. Merck Recent Developments
Table 106. Pfizer Company Details
Table 107. Pfizer Business Overview
Table 108. Pfizer Oral Antidiabetic Agents Product
Table 109. Pfizer Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 110. Pfizer Recent Developments
Table 111. Cipla Company Details
Table 112. Cipla Business Overview
Table 113. Cipla Oral Antidiabetic Agents Product
Table 114. Cipla Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 115. Cipla Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Antidiabetic Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Oral Antidiabetic Agents Market Share by Type: 2023 VS 2030
Figure 3. Sulfonylureas Features
Figure 4. Meglitinides Features
Figure 5. Biguanides Features
Figure 6. Thiazolidinediones Features
Figure 7. Alpha-glucosidase Inhibitors Features
Figure 8. Global Oral Antidiabetic Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Oral Antidiabetic Agents Market Share by Application: 2023 VS 2030
Figure 10. Home Use Case Studies
Figure 11. Medical Institutions Case Studies
Figure 12. Others Case Studies
Figure 13. Oral Antidiabetic Agents Report Years Considered
Figure 14. Global Oral Antidiabetic Agents Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Oral Antidiabetic Agents Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Oral Antidiabetic Agents Market Share by Region: 2023 VS 2030
Figure 17. Global Oral Antidiabetic Agents Market Share by Players in 2023
Figure 18. Global Top Oral Antidiabetic Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Agents as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Oral Antidiabetic Agents Revenue in 2023
Figure 20. North America Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Oral Antidiabetic Agents Market Share by Type (2019-2030)
Figure 22. North America Oral Antidiabetic Agents Market Share by Application (2019-2030)
Figure 23. North America Oral Antidiabetic Agents Market Share by Country (2019-2030)
Figure 24. United States Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Oral Antidiabetic Agents Market Size YoY (2019-2030) & (US$ Million)
Figure 27. Europe Oral Antidiabetic Agents Market Share by Type (2019-2030)
Figure 28. Europe Oral Antidiabetic Agents Market Share by Application (2019-2030)
Figure 29. Europe Oral Antidiabetic Agents Market Share by Country (2019-2030)
Figure 30. Germany Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. China Oral Antidiabetic Agents Market Size YoY (2019-2030) & (US$ Million)
Figure 37. China Oral Antidiabetic Agents Market Share by Type (2019-2030)
Figure 38. China Oral Antidiabetic Agents Market Share by Application (2019-2030)
Figure 39. Asia Oral Antidiabetic Agents Market Size YoY (2019-2030) & (US$ Million)
Figure 40. Asia Oral Antidiabetic Agents Market Share by Type (2019-2030)
Figure 41. Asia Oral Antidiabetic Agents Market Share by Application (2019-2030)
Figure 42. Asia Oral Antidiabetic Agents Market Share by Region (2019-2030)
Figure 43. Japan Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. South Korea Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Taiwan Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. India Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Australia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size YoY (2019-2030) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Share by Type (2019-2030)
Figure 51. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Share by Application (2019-2030)
Figure 52. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Share by Country (2019-2030)
Figure 53. Brazil Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Mexico Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Turkey Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Israel Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. GCC Countries Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Novo Nordisk Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 60. Eli Lilly Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 61. Sanofi Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 62. Roche Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 63. Teva Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 64. AstraZeneca Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 65. Wockhardt UK Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 66. Merck Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 67. Pfizer Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 68. Cipla Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Circuit Simulator Market Research Report 2025
Mar 11, 25
Global Schematic Editor Market Research Report 2025
Mar 11, 25
Global Milk Green Tea Market Research Report 2025
Mar 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232